- Bend Bulletin main site
- Bend Bulletin archives
- Terms of Use
- Privacy Policy
- Contact the Bulletin
- Comments/Questions?
Published daily in Bend, Oregon, by Western Communications, Inc. Copyright 2007.
By Natasha Singer / The Bulletin
January 27, 2009
NEW YORK — Molecules.
That’s the single word that might best sum up Pfizer’s pursuit of Wyeth.
Most other traditional big drug companies that have been seen as takeover candidates lately, like Bristol-Myers Squibb and Schering-Plough, still concentrate heavily on....
